Coleen Blanchfield
Psychiatry · Reston, VANPI 1558581314
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Axsome Therapeutics, Inc. accounts for 65.0% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $6,861, 4.4 times the $1,546 reported in 2019. Among psychiatry clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 127 payments — averaging $80.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$7K
- Livanova USA, Inc.$1K
- AbbVie$701
- Johnson & Johnson$498
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$244
- Alkermes, Inc.$140
- plus $665 from 15 others
What the payments were for
- Speaking & faculty fees$6,05059%
- Travel & lodging$8498%
- Food & beverage$3,16431%
- Education$1251%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 14 | $6,624 |
| Livanova USA, Inc. | 4 | $1,316 |
| AbbVie(2 entities) | 44 | $701 |
| Johnson & Johnson | 15 | $498 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $244 |
| Alkermes, Inc. | 7 | $140 |
| Corium, LLC | 8 | $107 |
| Harmony Biosciences LLC | 2 | $95 |
| Otsuka America Pharmaceutical, Inc. | 5 | $84 |
| Lundbeck LLC | 3 | $83 |
| Teva Pharmaceuticals USA, Inc. | 3 | $61 |
| Neurocrine Biosciences, Inc. | 3 | $47 |
| Amgen | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Vertical Pharmaceuticals, LLC | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| TMS Neurohealth Centers Inc. | 1 | $21 |
| Merck | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
| Travere Therapeutics, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$6,505
- VNS Therapy$1,316
- SPRAVATO$245
- VRAYLAR$226
- CAPLYTA$100
How this compares
$10,188 in reported general payments places this provider in the 95th percentile of 884 psychiatry providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuedextaDextromethorphan Hbr/Quinidine | 15 | $53,526 |
| TrintellixVortioxetine Hydrobromide | 41 | $28,177 |
| AristadaAripiprazole Lauroxil | 13 | $26,684 |
| AuvelityDextromethorphan Hbr/Bupropion | 19 | $24,080 |
| SavellaMilnacipran Hcl | 14 | $10,043 |
| Aripiprazole | 59 | $7,302 |
| VyvanseLisdexamfetamine Dimesylate | 12 | $4,514 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 47 | $2,953 |
| Vilazodone Hcl | 34 | $2,879 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 20 | $2,216 |
| Eszopiclone | 44 | $2,192 |
| Gabapentin | 130 | $1,877 |
| Oxcarbazepine | 13 | $1,846 |
| Temazepam | 56 | $1,754 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 71 | $1,742 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Avanir Pharmaceuticals, Inc.Nuedexta | $13 | $53,52615 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $25 | $32,69053 claims |
| Alkermes, Inc.Aristada | $140 | $26,68413 claims |
| Axsome Therapeutics, Inc.Auvelity | $6,624 | $24,08019 claims |
| AbbVieSavella | $701 | $10,04314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 884 psychiatry providers in Virginia.
Other psychiatry in Reston
- Niku SinghFalls Church$2.5M
- David ScheidererRoanoke$2.4M
- Kent McDanielGlen Allen$2.1M
- Jasdeep MiglaniManassas$958K
- David SpiegelNorfolk$565K
- William YetterVirginia Beach$312K
- Anita ClaytonCharlottesville$260K
- Robert GardellaStaunton$201K
- Timothy KaneStaunton$162K
- Ralph McKenzieRoanoke$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.